AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, Hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.

Current Report (Form 8-K | Period ending 2024-12-11)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Abbvie Inc (ABBV US)

Current Report (Form 8-K | Period ending 2024-12-11)

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-10-30)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)